Mrs Linda S Brown, CNM | |
642 Mcclellan Street, Suite 101, Schenectady, NY 12304-1020 | |
(518) 382-2260 | |
(518) 347-5007 |
Full Name | Mrs Linda S Brown |
---|---|
Gender | Female |
Speciality | Advanced Practice Midwife |
Location | 642 Mcclellan Street, Schenectady, New York |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1154450674 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367A00000X | Advanced Practice Midwife | F000790 (New York) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Linda S Brown, CNM 26 W Shore Dr, Averill Park, NY 12018-4826 Ph: (518) 674-3222 | Mrs Linda S Brown, CNM 642 Mcclellan Street, Suite 101, Schenectady, NY 12304-1020 Ph: (518) 382-2260 |
News Archive
Soligenix, Inc., formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today the publication of an article in the January 2010 edition of Infection and Immunity, detailing the characteristics of several immunodominant regions of ricin A chain, the antigenic component of RiVax((TM)). RiVax((TM)) is Soligenix's vaccine to protect against exposure to ricin toxin and is currently being evaluated in Phase 1 human safety and immunogenicity trials, as well as nonhuman primate trials for efficacy.
In the 1960s, health care across the Mississippi Delta was sparse and much of it was segregated. Some hospitals were dedicated to Black patients, but they often struggled to stay afloat.
Siddhartha Sikdar, Professor, Bioengineering, Volgenau School of Engineering, Parag Chitnis, Assistant Professor, Bioengineering, and Guoqing Diao, Associate Professor, Statistics, are working to develop and evaluate a prototype prosthetic control system that uses wearable ultrasound imaging sensors to sense residual muscle activity rather than electromyography.
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has signed an agreement with Tibotec Pharmaceuticals for a non-exclusive license to manufacture, market and distribute a generic version of the non-nucleoside reverse transcriptase inhibitor Rilpivirine Hydrochloride (TMC278), pending its regulatory approval for the treatment of treatment-naive HIV-1-infected adults.
A previously shelved drug could prove effective for treating a group of rare childhood cancers, and Cancer Research UK today announced it has been granted exclusive marketing rights for the drug in these indications by the European Commission and the Food and Drug Administration (FDA).
› Verified 2 days ago
Bridget T Talty, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 2123 River Rd, Schenectady, NY 12309 Phone: 518-381-1121 Fax: 518-381-3930 | |
Ms. Padi Sutherland, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 700 Mcclellan St Ste 206, Schenectady, NY 12304 Phone: 518-370-7937 Fax: 518-377-2983 | |
Ms. Marcy Adine Fiet, C.N.M. Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 700 Mcclellan St, Suite 206, Schenectady, NY 12304 Phone: 518-370-7937 Fax: 518-377-2983 |